Peptron, Inc. (087010.KQ)
KRW 98300.0
(-1.99%)
KRW 98300.0
(-1.99%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 16.65 Billion KRW | 7.99% |
| 2022 | 14.31 Billion KRW | -19.83% |
| 2021 | 17.85 Billion KRW | 7.84% |
| 2020 | 16.55 Billion KRW | 45.02% |
| 2019 | 11.41 Billion KRW | 24.06% |
| 2018 | 9.2 Billion KRW | 57.16% |
| 2017 | 5.85 Billion KRW | 25.43% |
| 2016 | 4.66 Billion KRW | 27.67% |
| 2015 | 3.65 Billion KRW | 1.17% |
| 2014 | 3.61 Billion KRW | 36.51% |
| 2013 | 2.64 Billion KRW | 14.51% |
| 2012 | 2.31 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.68 Billion KRW | 4.24% |
| 2024 Q1 | 3.53 Billion KRW | 21.0% |
| 2023 Q4 | 2.92 Billion KRW | -21.29% |
| 2023 Q1 | 3.72 Billion KRW | 6.65% |
| 2023 Q3 | 3.71 Billion KRW | -28.23% |
| 2023 Q2 | 5.17 Billion KRW | 38.94% |
| 2023 FY | 15.45 Billion KRW | 7.99% |
| 2022 Q4 | 3.49 Billion KRW | 6.15% |
| 2022 Q3 | 3.29 Billion KRW | -17.03% |
| 2022 Q2 | 3.96 Billion KRW | 11.48% |
| 2022 Q1 | 3.55 Billion KRW | -17.12% |
| 2022 FY | 14.31 Billion KRW | -19.83% |
| 2021 Q3 | 4.07 Billion KRW | -12.65% |
| 2021 Q1 | 4.81 Billion KRW | -5.84% |
| 2021 FY | 17.85 Billion KRW | 7.84% |
| 2021 Q2 | 4.66 Billion KRW | -3.14% |
| 2021 Q4 | 4.29 Billion KRW | 5.36% |
| 2020 Q1 | 3.82 Billion KRW | -62.09% |
| 2020 FY | 16.55 Billion KRW | 45.02% |
| 2020 Q4 | 5.11 Billion KRW | 7.95% |
| 2020 Q3 | 4.73 Billion KRW | -18.42% |
| 2020 Q2 | 5.8 Billion KRW | 52.06% |
| 2019 Q3 | 3.99 Billion KRW | 103.91% |
| 2019 Q2 | 1.95 Billion KRW | -24.41% |
| 2019 FY | 11.41 Billion KRW | 24.06% |
| 2019 Q1 | 2.58 Billion KRW | 93.89% |
| 2019 Q4 | 10.07 Billion KRW | 152.49% |
| 2018 Q1 | 1.82 Billion KRW | 7.13% |
| 2018 Q3 | 2.77 Billion KRW | 1058.57% |
| 2018 FY | 9.2 Billion KRW | 57.16% |
| 2018 Q4 | 1.33 Billion KRW | -51.82% |
| 2018 Q2 | 239.26 Million KRW | -86.91% |
| 2017 Q3 | 1.32 Billion KRW | -19.92% |
| 2017 Q2 | 1.65 Billion KRW | 13.73% |
| 2017 Q1 | 1.45 Billion KRW | 0.06% |
| 2017 FY | 5.85 Billion KRW | 25.43% |
| 2017 Q4 | 1.7 Billion KRW | 28.47% |
| 2016 Q3 | 1.05 Billion KRW | -2.68% |
| 2016 Q1 | 1.02 Billion KRW | 19.85% |
| 2016 FY | 4.66 Billion KRW | 27.67% |
| 2016 Q2 | 1.08 Billion KRW | 5.43% |
| 2016 Q4 | 1.45 Billion KRW | 37.91% |
| 2015 Q3 | 1.07 Billion KRW | 31.25% |
| 2015 FY | 3.65 Billion KRW | 1.17% |
| 2015 Q4 | 859.18 Million KRW | -19.76% |
| 2015 Q2 | 815.83 Million KRW | -4.36% |
| 2015 Q1 | 853.02 Million KRW | 0.0% |
| 2014 FY | 3.61 Billion KRW | 36.51% |
| 2014 Q2 | 847.66 Million KRW | 0.24% |
| 2014 Q1 | 845.64 Million KRW | 0.0% |
| 2014 Q3 | 1.09 Billion KRW | 29.57% |
| 2013 FY | 2.64 Billion KRW | 14.51% |
| 2012 FY | 2.31 Billion KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| HLB Co., Ltd. | 109.98 Billion KRW | 84.856% |
| iNtRON Biotechnology, Inc. | 7.84 Billion KRW | -112.298% |
| BINEX Co., Ltd. | 55.67 Billion KRW | 70.083% |
| Bioneer Corporation | 204.55 Billion KRW | 91.857% |
| Anterogen.Co.,Ltd. | 7.74 Billion KRW | -115.196% |
| MEDIPOST Co., Ltd. | 65.31 Billion KRW | 74.498% |
| CrystalGenomics, Inc. | 32.36 Billion KRW | 48.543% |
| Helixmith Co., Ltd | 37.36 Billion KRW | 55.425% |
| Chabiotech Co.,Ltd. | 285.93 Billion KRW | 94.175% |
| Medy-Tox Inc. | 110.88 Billion KRW | 84.979% |
| Amicogen, Inc. | 52.82 Billion KRW | 68.467% |
| Genexine, Inc. | 41.62 Billion KRW | 59.987% |
| HLB Therapeutics Co.,Ltd. | 16.16 Billion KRW | -3.031% |
| LegoChem Biosciences, Inc. | 98.61 Billion KRW | 83.11% |
| ALTEOGEN Inc. | 40.93 Billion KRW | 59.31% |
| PharmaResearch Co., Ltd. | 89.44 Billion KRW | 81.377% |
| SillaJen, Inc. | 5.11 Billion KRW | -225.817% |
| JETEMA, Co., Ltd. | 25.66 Billion KRW | 35.098% |
| OliX Pharmaceuticals,Inc | 35.24 Billion KRW | 52.747% |
| Genomictree Inc. | 16.26 Billion KRW | -2.408% |
| MedPacto, Inc. | 26.91 Billion KRW | 38.124% |
| D&D Pharmatech | 32.16 Billion KRW | 48.212% |
| EASY BIO,Inc. | 29.67 Billion KRW | 43.864% |
| GI Innovation, Inc. | 57.59 Billion KRW | 71.079% |